These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of dialysis membranes on interleukin-1 beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells. Higuchi T; Kuno T; Takahashi S; Kanmatsuse K Artif Organs; 1997 Apr; 21(4):265-71. PubMed ID: 9096797 [TBL] [Abstract][Full Text] [Related]
3. Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes. Frith SE; Hoenich NA; Redfern CP; Goodship TH Int J Artif Organs; 1994 Sep; 17(9):478-87. PubMed ID: 7890436 [TBL] [Abstract][Full Text] [Related]
4. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829 [TBL] [Abstract][Full Text] [Related]
5. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891 [TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury. Mandrup-Poulsen T; Wogensen LD; Jensen M; Svensson P; Nilsson P; Emdal T; Mølvig J; Dinarello CA; Nerup J Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382 [TBL] [Abstract][Full Text] [Related]
7. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients. Gu Y; Ding F; Qin H; Zhao H; Lin S Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226 [TBL] [Abstract][Full Text] [Related]
8. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells. Linnenweber S; Lonnemann G Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027 [TBL] [Abstract][Full Text] [Related]
9. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Pereira BJ; Poutsiaka DD; King AJ; Strom JA; Narayan G; Levey AS; Dinarello CA Kidney Int; 1992 Dec; 42(6):1419-24. PubMed ID: 1474775 [TBL] [Abstract][Full Text] [Related]
10. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. O'Nualláin EM; Puri P; Mealy K; Reen DJ Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis. Müller K; Zak M; Nielsen S; Pedersen FK; de Nully P; Bendtzen K Clin Exp Rheumatol; 1997; 15(4):439-44. PubMed ID: 9272308 [TBL] [Abstract][Full Text] [Related]
12. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study. Donati D; Degiannis D; Homer L; Raska K; Raskova J Am J Nephrol; 1991; 11(6):451-8. PubMed ID: 1819211 [TBL] [Abstract][Full Text] [Related]
13. Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production. Poutsiaka DD; Mengozzi M; Vannier E; Sinha B; Dinarello CA Blood; 1993 Dec; 82(12):3695-700. PubMed ID: 7505123 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications? Dinarello CA Nephrol Dial Transplant; 1995; 10 Suppl 3():25-8. PubMed ID: 7494610 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 receptor antagonist: an index of dialysis-induced interleukin-1 production. Pereira BJ; King AJ; Falagas ME; Dinarello CA Nephron; 1994; 67(3):358-61. PubMed ID: 7936030 [TBL] [Abstract][Full Text] [Related]
17. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients. Farrell J; Bastani B Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041 [No Abstract] [Full Text] [Related]
18. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood. Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146 [TBL] [Abstract][Full Text] [Related]
20. Cytokine antagonists in aged subjects and their relation with cellular immunity. Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]